Ctc LLC Bio N Tech Se Transaction History

Ctc LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$90.91 - $112.75 $122,819 - $152,325	-1,351 Reduced 24.68%	4,124 $435,000
Q3 2023 Oct 31, 2023	SELL	$98.5 - $125.08 $760,715 - $965,992	-7,723 Reduced 58.52%	5,475 $594,000
Q2 2023 Aug 04, 2023	SELL	$102.58 - $129.66 $1.31 Million - $1.66 Million	-12,782 Reduced 49.2%	13,198 $1.42 Million
Q1 2023 May 22, 2023	BUY	$122.57 - $153.67 $2.27 Million - $2.85 Million	18,542 Added 249.29%	25,980 $3.24 Million
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $880,882 - $1.38 Million	7,438 New	7,438 $1.12 Million
Q1 2022 May 09, 2022	SELL	$126.25 - $231.85 $5.13 Million - $9.41 Million	-40,605 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $617,640 - $1.03 Million	2,851 Added 7.55%	40,605 $10.5 Million
Q3 2021 Oct 19, 2021	BUY	$205.93 - $447.23 $7.77 Million - $16.9 Million	37,754 New	37,754 $10.3 Million

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

Stay updated on Ctc LLC with notifications on news.